Recipients of Research Funds
PAUL MARONI, MD
Associate Professor, Surgery-Urology
“Thanks to support from Cancer League of Colorado, I have been able to jump start a clinical trial using grape seed extract in patients with non-metastatic prostate cancer. This is just one way that private funding is accelerating progress and hopefully changing lives.”
S. LINDSEY DAVIS, MD
Assistant Professor, Division of Medical Oncology
“Because of your outstanding support, our patients are experiencing better outcomes. The clinical trials that you have funded are certain to push the field forward. I believe that the research we are doing today will have a tangible impact on lives tomorrow.”
ELISSA KOLVA, PHD
Assistant Professor, Division of Medical Oncology
“Thank you for your continued support for clinical trials at the CU Cancer Center. So often, clinical trials are not sustained because of a lack of funding. By providing these critical funds, we can complete clinical trials and bring new therapies to patients more quickly than ever before.”
CHRISTINE FISHER, MD, MPH
Vice Chair of Education, Associate Professor and Residency Program Director, Department of Radiation Oncology
“Our clinical trial specifically studies radiation and anti-PD-1 therapy in recurrent women’s cancers. Thanks to your support, we are ready to begin recruiting patients to participate and hope to start seeing patients soon.”
ROSS CAMIDGE, MD, PHD
Professor, Division of Medical Oncology
“Our study is exploring the potential differential need for anti-resorptive bone medication in patients with advanced nonsmall cell lung cancer and bone metastases. Since we opened accrual in April, we have three subjects who have consented.
We hope to complete the clinical trial in 2022. You are helping make this research possible, and providing a valuable service to
current and future patients.”
University of Colorado Cancer Center has received more than $9.5 million in support since 1985
"We have accomplished so much over the years due to your support. The milestones we have reached as a Cancer Center would not have been possible without your longstanding partnership."